Unusual case of Pneumocystis jiroveci pneumonia during primary HIV infection

AIDS Reader

Volumn 18, Issue 6, 2008, Pages 313-317

  Byers, David K ^a   Decker, Catherine F ^a  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

Author keywords

HIV AIDS; Pneumocystis jiroveci pneumonia; Primary HIV infection

Indexed keywords

EFAVIRENZ; EMTRICITABINE; TENOFOVIR; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; AZITHROMYCIN; CEFTRIAXONE; COTRIMOXAZOLE; CREATININE; HEMOGLOBIN; LACTATE DEHYDROGENASE; PREDNISONE; VIRUS RNA;

ADULT; ARTICLE; CASE REPORT; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PNEUMOCYSTIS PNEUMONIA; SEROLOGY; WESTERN BLOTTING; ABNORMAL RESPIRATORY SOUND; ANEMIA; ANOREXIA; BRONCHOSCOPY; CARBON DIOXIDE TENSION; CD8+ T LYMPHOCYTE; COUGHING; CRACKLE; DIARRHEA; DYSPNEA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEVER; LUNG ALVEOLUS OXYGEN TENSION; MALE; NIGHT SWEAT; OPPORTUNISTIC INFECTION; OXYGEN TENSION; PH; PULSE OXIMETRY; RASH; RESPIRATORY DISTRESS; TACHYCARDIA; THORAX RADIOGRAPHY; THRUSH; WEIGHT REDUCTION;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; HUMANS; MALE; PNEUMOCYSTIS JIROVECII; PNEUMONIA, PNEUMOCYSTIS; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 84964690591     PISSN: 10530894     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Schacker T, Collier AC, Hughes J, et al. Clinical and epidemiologic features of primary HIV infection [published correction appears in Ann Intern Med. 1997;126:174]. Ann Interm Med. 1996;125:257-264.
2. Tindall B, Barker S, Donovan B, et al. Characterization of the acute clinical illness associated with human immunodeficiency virus infection. Arch Intern Med. 1988;148:945-949.
3. Daar E, Little S, Pitt J, et al. Diagnosis of primary HIV-1 infection. Los Angeles County Primary HIV Infection Recruitment Network. Ann Intern Med. 2001;134:25-29.
4. Sun HY, Chen MJ, Hung CC, et al. Clinical presentations and virologic characteristics of primary human immunodeficiency virus type-1 infection in a university hospital in Taiwan. J Microbiol Immunol Infect. 2004;37:271-275.
5. Kinloch-de Loès S, de Saussure P, Saurat JH, et al. Symptomatic primary infection due to human immunodeficiency virus type 1: review of 31 cases. Clin Infect Dis. 1993;17:59-65.
6. Kahn JO, Walker BD. Acute human immunodeficiency virus type 1 infection. N Engl J Med. 1998;339:33-39.
7. Pedersen C, Lindhardt BO, Jensen BL, et al. Clinical course of primary HIV infection: consequences for subsequent course of infection. BMJ. 1989;299:154-157.
8. Hirschel B. Primary HIV infection. In: Cohen J, Powderly WG, Berkley SF, et al, eds. Infectious Diseases. 2nd ed. St Louis: Mosby; 2003:1257-1262.
9. Levin ML, Palella F, Shah S, et al. HIV-associated nephropathy occurring before HIV antibody seroconversion. Am J Kidney Dis. 2001;37:e39.
10. Tattevin P, Camus C, Arvieux C, et al. Multiple organ failure during primary HIV infection. Clin Infect Dis. 2007;44:e28-e29.
11. Newton PJ, Newsholme W, Brink NS, et al. Acute meningoencephalitis and meningitis due to primary HIV infection. BMJ. 2002;325:1225-1227.
12. Narciso P, Galgani S, Del Grosso B, et al. Acute disseminated encephalomyelitis as manifestation of primary HIV infection. Neurology. 2001;57:1493-1496.
13. Mogenson T, Marinovskij E, Larsen C. Acute demyelinizating encephalomyelitis (ADEM) as initial presentation of primary HIV infection. Scan J Infect Dis. 2007;39:630-634.
14. Abad S, Touze E, Blanche P, et al. Shoulder girdle syndrome revealing primary HIV infection. Clin Infect Dis. 2002;34:1162-1163.
15. Zeman A, Donaghy M. Acute infection with human immunodeficiency virus presenting with neurogenic urinary retention. Genitourin Med. 1991;67:345-347.
16. Guillaume MP, Van Beers D, Delforge ML, et al. Primary human immunodeficiency virus infection presenting as myopericarditis and rhabdomyolysis. Clin Infect Dis. 1995;21:451-452.
17. Szabo S, James C, Telford G. Unusual presentations of primary human immunodeficiency virus infection. AIDS Patient Care STDS. 2002;16:251-254.
18. Vento S, Di Perri G, Garofano T, et al. Pneumocystis carinii pneumonia during primary HIV-1 infection. Lancet. 1993;342:24-25.
19. Pedersen C, Nielsen J, Dickmeis E, Jordal R. Early progression to AIDS following primary HIV infection. AIDS. 1989;3:45-47.
20. Decker C, Tiernan R, Paparello S. Esophageal candidiasis associated with acute infection due to human immunodeficiency virus. Clin Infect Dis. 1992;14:791.
21. Mientjes GH, van Ameijden EJ, Weigel HM, et al. Clinical symptoms associated with seroconversion for HIV-1 among misusers of intravenous drugs: comparison with homosexual seroconverters and non-infected intravenous drug misusers. BMJ. 1993;306:371-373.
22. Tindall B, Hing M, Edwards P, et al. Severe clinical manifestations of primary HIV infection. AIDS. 1989;3:747-749
23. Capetti A, Piconi S, Magni C, et al. Unusual presentation of acute cytomegalovirus disease during primary HIV-1 infection: antigen specific T-cell response analysis and clinical outcomes. AIDS. 2006;20:1566-1567.
24. Signorini L, Gulletta M, Coppini D, et al. Fatal disseminated toxoplasmosis during primary HIV infection. Curr HIV Res. 2007;5:273-274.
25. Schacker T, Hughes J, Shea T, et al. Biological and virologic characteristics of primary HIV infection. Ann Intern Med. 1998;128:613-620.
26. Cooper DA, Gold J, Maclean P, et al. Acute AIDS retrovirus infection. Definition of a clinical illness associated with seroconversion. Lancet. 1985;1:537-540.
27. Fox R, Eldred L, Fuchs E, et al. Clinical manifestations of acute infection with human immunodeficiency virus in a cohort of gay men. AIDS. 1987;1:35-38.
28. Marmor M, Titus S, Harrison C, et al. Weight loss associated with HIV seroconversion among injection-drug users. J Acquir Immune Defic Syndr Hum Retrovirol. 1996;12:514-518.
29. Rastegar D, Claiborne C, Fleisher A, Matsumoto A. A patient with primary human immunodeficiency virus infection who presented with acute rhabdomyolysis. Clin Infect Dis. 2001;32:502-504.
30. Tyner R, Turett G. Primary human immunodeficiency virus infection presenting as acute pancreatitis. South Med J. 2004;97:393-394.
31. Longworth D, Spech T, Ahmad M, et al. Lymphocytic alveolitis in primary HIV infection. Cleve Clin J Med. 1990;57:379-382.
32. Ruiz-Laigleasia FJ, Torrubia-Pérez CB, Pérez-Calvo JI. Ulcerative esophagitis during primary HIV infection. Arch Intern Med. 1996;156:1115.
33. Barrier J, Bani-Sadr F, Raffi F. Spontaneous rupture of the spleen revealing primary human immunodeficiency virus infection. Clin Infect Dis. 1997;25:336-337.
34. Cossarizza A. T-cell repertoire and HIV infection: facts and perspectives. AIDS. 1997;11:1075-1088.
35. Busch MP, Satten GA. Time course of viremia and antibody seroconversion following human immunodeficiency virus exposure. Am J Med. 1997;102:117-124.
36. Kassutto S, Rosenberg ES. Primary HIV type 1 infection. Clin Infect Dis. 2004;38:1447-1453.
37. Gaines H, von Sydow M, Sonnerborg A, et al. Antibody response in primary human immunodeficiency virus infection. Lancet. 1987;1:1249-1253.
38. Sinicco A, Palestro G, Caramello P, et al. Acute HIV-1 infection: clinical and biological study of 12 patients. J Acquir Immune Defic Syndr. 1990;3:260-265.
39. Clark SJ, Saag MS, Decker WD, et al. High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection. N Engl J Med. 1991;324:954-960.
40. Niu MT, Stein DS, Schnittman SM. Primary human immunodeficiency virus type 1 infection: review of pathogenesis and early treatment intervention in humans and animal retrovirus infections. J Infect Dis. 1993;168:1490-1501.
41. Janssen RS, Satten GA, Stramer SL, et al. New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes [published correction appears in JAMA. 1999;281:1893]. JAMA 1998;280:42-48.
42. Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antiretroviral therapy: a collaborative re-analysis. Collaborative Group on AIDS Incubation and HIV Survival including the CASCADE EU Concerted Action. Concerted Action on Seroconversion to AIDS and Death in Europe. Lancet. 2000;355:1131-1137.
43. Steckelberg JM, Cockerill FR 3rd. Serologic testing for human immunodeficiency virus antibodies. Mayo Clin Proc. 1988;63:373-380.
44. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1 infected adults and adolescents. Department of Health and Human Services. January 29, 2008; 1-128. http://www.aidsinfo.nih.gov/contentfiles/AdultandAdolescentGL.pdf. Accessed May 16, 2008.
45. Shelburne SA, Visnegarwala F, Darcourt J, et al. Incidence and risk factors for immune reconstitution syndrome during highly active antiretroviral therapy. AIDS. 2005;19:399-406.
46. Zolopa A, Andersen K, Komarow L, et al. Immediate vs deferred ART in the setting of acute AIDS-related opportunistic infection: final results of a randomized strategy trial, ACTG A5164. 15th Conference on Retroviruses and Opportunistic Infections; February 3-6, 2008; Boston. Abstract 142.